BioLineRx Provides Update on Phase 2 Open-Label Study for BL … – PR Newswire (press release)
BioLineRx Provides Update on Phase 2 Open-Label Study for BL …PR Newswire (press release)BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, reported partial results data from its …..